DANIELS: Will we protect our kids, or won’t we?
As a society, we do everything we can to protect our children from harm and prepare them to live productive and successful lives.
Home » Search
Search Results
7,376 results for 'Search IBJ.com'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
2013 Forty Under 40: Chasity Q. Thompson
As a lawyer working in higher education to help other lawyers, Chasity Thompson believes she has the best of both worlds.
2013 Forty Under 40: Una Osili
Una Osili has one foot in the global community and the other in Indianapolis. A renowned researcher on philanthropic trends, she also is a wife and mother who serves on St. Richard’s Episcopal School board and helped her husband, Vop Osili, campaign for public office.
2013 Forty Under 40: Michele Jackson
Michele Jackson splits her week between her Harden Jackson Law LLC firm, where she handles domestic adoptions and reproductive law cases, and MLJ Adoptions, where she specializes in the sometimes exhilarating, sometimes heartbreaking world of international adoption.
2013 Forty Under 40: Laura E. Henderson
As founder and executive director of Growing Places Indy, Laura Henderson sees the big picture. People making healthier food choices feel better, and when many people feel better, the result is a healthier community.
2013 Forty Under 40: Chris T. Gahl
Chris Gahl is passionate about his hometown. As vice president of marketing and communication for Visit Indy, he turns his enthusiasm loose on meeting planners and travel professionals, showing them the best Indianapolis has to offer, which was on display for millions in 2012 during Super Bowl XLVI.
2013 Forty Under 40: Katie Culp
Katie Culp has amassed enough frequent flier miles to move up to first class frequently. That’s good not only because she’s 5-foot-11 but also because she does a fair amount of traveling.
ChaCha secures $14M investment to expand services
The latest round of funding will enable ChaCha to make “significant” investments in new products to expand both mobile and online services, CEO Scott Jones said. Internally, the project is dubbed “Go Big.”
Verge on verge of growing up
With more than 2,000 members attending monthly events organized by chapters in Indianapolis, Bloomington and West Lafayette, tech entrepreneurship group Verge is poised to expand, outgoing executive director Matt Hunckler says.
BioCrossroads: Life sciences a $50B industry in Indiana
The life sciences industry in Indiana employs 55,500 workers paying average wages of more than $88,500 per year, according to new figures released Tuesday by Indianapolis-based life sciences development group BioCrossroads.
Company news
Two new health clinics opened on the west side of Indianapolis last week. HealthNet Inc. opened a community health center on West 10th Street, providing primary, pediatric and OB/GYN care, as well as optomemtry, podiatry, behavioral health and social work services. Also, Community Health Network opened a medical office building in Speedway, which is part of its westward expansion after its acquisition of Westview Hospital on West 38th Street. The offices offer primary care, walk-in care, imaging, infusion therapy and occupational health services. Community also will work with the new Marian University College of Osteopathic Medicine to conduct training for medical residents in Speedway.
WellPoint Inc. is still considering former Amerigroup Corp. CEO James Carlson among several finalists to become CEO, Bloomberg News reported, citing a person familiar with the matter. The Indianapolis-based health insurer has delayed defining a role for Carlson, who joined WellPoint through its $4.9 billion acquisition of Amerigroup in December, because he is a contender for the top position, said the person, who asked for anonymity because the information is private. Retired Aetna Inc. CEO Ronald Williams also has been a leading candidate, according to people with knowledge of the deliberations. Carlson, 60, would replace Angela Braly, who was forced out in August amid investor complaints about the company's performance. Carlson built Amerigroup into one of the biggest insurers focused on the growing Medicaid sector. In an e-mail, Kristin Binns, a WellPoint spokeswoman, said the company wouldn’t comment on the CEO search. Maureen McDonnell, an Amerigroup spokeswoman, also declined to discuss the process or Carlson’s role. Katherine Mentus, a spokesman for Williams, declined to comment when reached by telephone. Analysts expect WellPoint to make a decision by the end of February.
Eli Lilly and Co. will have to conduct more studies of its experimental Alzheimer’s drug, but it is getting some outside help. Researchers at Brigham and Women’s Hospital in Boston chose Lilly’s drug solanezumab for a large federally funded study testing whether it's possible to prevent Alzheimer's disease in older people at high risk of developing it, according to the Associated Press. Lilly’s own studies of solanezumab found that it did not help people with moderate to severe Alzheimer's, but it showed some promise against milder disease. Researchers think it might work better if given before symptoms start. The new study will enroll 1,000 patients between age 70 and 85 who show a buildup of plaques in their brains but do not yet show signs of Alzheimer’s, including loss of memory and ability to do daily activities. Lilly’s solanezumab is also one of two drugs being studied in Alzheimer’s patients by researchers at Washington University. The other is made by the Genentech unit of Switzerland-based Roche Holding AG.
Indianapolis-based Defender Direct, a home security dealer, has opened an on-site health clinic, joining a number of other area employers that offer such services. Defender Direct’s 650 employees and their families now can receive primary care at the East 96th Street clinic, operated by Indianapolis-based OurHealth. Indianapolis-based MJ Insurance, which has helped such employers as Interactive Intelligence Inc. and others set up onsite clinics, brokered the deal.
Roche Diagnostics Corp. in Indianapolis ranks 89th on Fortune magazine’s latest annual list of the “100 Best Companies to Work For,” the magazine announced Thursday. In selecting Roche, the only Indiana company to appear on the list, Fortune cited its on-site medical clinic and fitness center, the company's $30,000 budget for intramural sports, and its health insurance plans tiered to income levels. The Indianapolis campus serves as the North American headquarters for the diagnostics business of Switzerland-based Roche Holding AG.
Pence wants $1.5M a year for life sciences institute
The Indiana Applied Research Enterprise already has received support from John Lechleiter, CEO of Indianapolis-based Eli Lilly and Co., as a place for collaboration between academic and industrial scientists.
Lilly drug chosen for Alzheimer’s prevention study
Researchers have chosen an experimental drug by Eli Lilly and Co. for a large federally funded study testing whether it's possible to prevent Alzheimer's disease in older people at high risk of developing it.
BENNER: When our heroes fail, we love to take it personally
Few things rouse us more than a fall from grace, and the more precipitous, the better. Sports so deliciously delivers grist for our grindstone time and again.
Priority list: A&E choices for Jan. 24-30
Tiempo Libre at Clowes Hall and “Next to Normal” at the Phoenix Theatre among this week’s picks.
Company news
BioCrossroads Inc.’s newest seed fund has plowed $750,000 into two Indianapolis-area life sciences companies. Esanex Inc. received $500,000 to help it develop a therapy that inhibits the ability of cancer cells to grow and survive. The investment will be used to complete a Phase 1 study in patients with tumors and to conduct multiple Phase 2 trials. Esanex is part of the portfolio of Lilly Ventures, the venture capital firm spun out of Eli Lilly and Co. in 2009. Algaeon Inc., meanwhile, received $250,000 to develop a technology for making micro-algae-based products used in human supplements and in animal and fish-feed stocks. The company will use the investment to expand operations and produce additional products. Algaeon is located on the northwest side on West 82nd Street. BioCrossroads, the Indianapolis-based life sciences development group, launched Indiana Seed Fund II in April after raising $8.25 million to help fledgling life sciences companies grow. Its first seed fund raised $6 million that was invested in 11 companies.
WellPoint Inc.’s plan to raise rates that small employers in California pay for medical insurance was criticized as unreasonable by the state insurance commissioner, who said customers are being charged this year to cover U.S. health-law taxes that won’t begin until 2014. According to Bloomberg News, WellPoint’s Anthem Blue Cross unit in California is raising those rates an average of 10.6 percent. Indianapolis-based WellPoint sells small group policies that cover 284,000 California employees. California Insurance Commissioner Dave Jones accused WellPoint of overstating future medical use and cost trends, and improperly including next year’s taxes. The commissioner provided his findings last month to the insurer, which plans to proceed with the rate increase. Anthem Blue Cross said rates will go up an average of 6.5 percent and the increase is lower than not-for-profit competitors. Around the country, Aetna Inc., UnitedHealth Group, Centene Corp. and other health insurers have proposed large increases on small businesses and individual buyers in recent months, citing rising costs for medical care and greater requirements of the health-care law. The Obama administration has said provisions in the law have kept increases from being even higher.
Johnson & Johnson won the backing of an FDA advisory panel for a diabetes pill the company is seeking to make the first in a new family of drugs for managing blood sugar, putting it ahead of Eli Lilly and Co., Bristol-Myers Squibb Co. and AstraZeneca plc, which all are trying to develop similar drugs. According to Bloomberg News, New Jersey-based J&J received a 10-5 vote from the panel to support its drug canagliflozin, although the panel also said the drug raises concerns about heart risks. The once-a-day pill is part of a treatment group known as SGLT2 inhibitors that are intended to have fewer side effects, such as low blood sugar and weight gain, than current diabetes drugs. The U.S. Food and Drug Administration is scheduled to decide on canagliflozin by the end of March; the agency usually follows recommendations of its advisory panels, but it does not have to. Lilly’s drug, which it is developing with Germany-based Boehringer Ingelheim Gmbh, is called empagliflozin. The two companies plan to file for FDA approval later this year.
Catheter Research Inc. has acquired assets from Illinois-based Marshall Medical Systems & Equipment Inc., one of the distributors of medical equipment for a subsidiary of Catheter Research called Thomas Medical Systems. Thomas Medical makes medical devices for reproductive and OB/GYN care. Catheter Research did not disclose the purchase price.
New art museum CEO shakes up management team
The new head of the Indianapolis Museum of Art has reduced the size of his executive team, including cutting a top position, as an initial step to organization-wide restructuring.
Cassidy Turley offers mixed outlook on Indy real estate
The city's largest real estate brokerage expects the industrial and housing markets to boom in 2013, but offers a more cautious view on the office and retail sectors, predicting that uncertainty caused by political gridlock could hamper an already sluggish recovery.
WRTV promotes from within to fill news director opening
The local ABC affiliate named Terri Cope-Walton to fill the position that’s been open since November. The station veteran had served as interim news director and previously was assistant news director.